Sanders Morris Harris’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,000
| Closed | -$272K | – | 179 |
|
|
2025
Q1 | $272K | Hold |
4,000
| – | – | 0.04% | 221 |
|
|
2024
Q4 | $263K | Hold |
4,000
| – | – | 0.04% | 239 |
|
|
2024
Q3 | $281K | Hold |
4,000
| – | – | 0.05% | 221 |
|
|
2024
Q2 | $329K | Hold |
4,000
| – | – | 0.05% | 202 |
|
|
2024
Q1 | $349K | Hold |
4,000
| – | – | 0.06% | 193 |
|
|
2023
Q4 | $396K | Hold |
4,000
| – | – | 0.19% | 131 |
|
|
2023
Q3 | $346K | Hold |
4,000
| – | – | 0.07% | 181 |
|
|
2023
Q2 | $344K | Buy |
+4,000
| New | +$344K | 0.08% | 179 |
|
|
2023
Q1 | – | Sell |
-4,000
| Closed | -$414K | – | 155 |
|
|
2022
Q4 | $414K | Hold |
4,000
| – | – | 0.16% | 129 |
|
|
2022
Q3 | $347K | Hold |
4,000
| – | – | 0.09% | 178 |
|
|
2022
Q2 | $340K | Hold |
4,000
| – | – | 0.07% | 189 |
|
|
2022
Q1 | $308K | Hold |
4,000
| – | – | 0.06% | 220 |
|
|
2021
Q4 | $354K | Hold |
4,000
| – | – | 0.06% | 215 |
|
|
2021
Q3 | $311K | Hold |
4,000
| – | – | 0.06% | 232 |
|
|
2021
Q2 | $338K | Hold |
4,000
| – | – | 0.07% | 232 |
|
|
2021
Q1 | $312K | Hold |
4,000
| – | – | 0.07% | 221 |
|
|
2020
Q4 | $328K | Hold |
4,000
| – | – | 0.07% | 215 |
|
|
2020
Q3 | $320K | Buy |
4,000
+250
| +7% | +$20K | 0.09% | 198 |
|
|
2020
Q2 | $472K | Buy |
+3,750
| New | +$472K | 0.23% | 57 |
|